Is SIOX or NOBL a better dividend investment in 2026?

SIOX currently yields 91.00% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: SIOX offers higher current income.

What is the dividend yield difference between SIOX and NOBL?

SIOX has a forward dividend yield of 91.00% ($0.43/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 88.83 percentage points.

Home › Compare › SIOX vs NOBL

SIOX vs NOBL: Dividend Comparison 2026

SIOX yields 91.00% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SIOX wins by $2.66M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SIOX

● Live price

91.00%

Share price

$0.48

Annual div

$0.44

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.68M

Annual income

$847,016.42

Full SIOX calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — SIOX vs NOBL

📍 SIOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SIOX	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SIOX + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SIOX pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIOX

Annual income on $10K today (after 15% tax)

$7,735.36/yr

After 10yr DRIP, annual income (after tax)

$719,963.96/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, SIOX beats the other by $719,751.64/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIOX + NOBL for your $10,000?

SIOX: 50%NOBL: 50%

100% NOBL50/50100% SIOX

Portfolio after 10yr

$1.35M

Annual income

$423,633.10/yr

Blended yield

31.37%

📊

Analyst Conviction Gap

Where Wall Street is split right now

SIOX

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Altman Z

-17.3

Piotroski

2/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIOX buys

NOBL buys

No recent congressional trades found for SIOX or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSIOXNOBL

Forward yield	91.00% ✓	2.17%
Annual dividend / share	$0.44	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2.68M	$22.9K ✓
Annual income after 10y	$847,016.42 ✓	$249.78
Total dividends collected	$2.37M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SIOX vs NOBL ($10,000, DRIP)

Year	SIOX Portfolio	SIOX Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$19,800	$9,100.42	$10,917	$217.08	+$8.9K → SIOX
2	$38,027	$16,840.38	$11,903	$221.48	+$26.1K → SIOX
3	$70,915	$30,226.23	$12,962	$225.68	+$58.0K → SIOX
4	$128,559	$52,680.24	$14,099	$229.68	+$114.5K → SIOX
5	$226,813	$89,254.37	$15,319	$233.49	+$211.5K → SIOX
6	$389,856	$147,166.82	$16,628	$237.10	+$373.2K → SIOX
7	$653,555	$236,408.67	$18,033	$240.53	+$635.5K → SIOX
8	$1,069,692	$370,388.16	$19,539	$243.78	+$1.05M → SIOX
9	$1,711,136	$566,565.23	$21,154	$246.86	+$1.69M → SIOX
10	$2,677,932	$847,016.42	$22,884	$249.78	+$2.66M → SIOX

SIOX vs NOBL: Complete Analysis 2026

SIOX — Stock

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.

Full SIOX Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this SIOX vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIOX vs SCHD SIOX vs JEPI SIOX vs O SIOX vs KO SIOX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.